Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 169Neoplasms 128Prostatic Neoplasms 92Lung Neoplasms 82Colorectal Neoplasms 80Pancreatic Neoplasms 38Leiomyoma 37Carcinoma, Hepatocellular 36Lymphoma, Follicular 35Carcinoma, Non-Small-Cell Lung 30Neoplasm Metastasis 27Skin Neoplasms 26Colonic Neoplasms 26Uterine Cervical Neoplasms 25Liver Neoplasms 25Multiple Myeloma 23Glioblastoma 22Head and Neck Neoplasms 21Barrett Esophagus 21Polycystic Ovary Syndrome 19Brain Neoplasms 18Urinary Bladder Neoplasms 17Polyps 16Ovarian Neoplasms 15Esophageal Neoplasms 15Stomach Neoplasms 14Squamous Cell Carcinoma of Head and Neck 14Rectal Neoplasms 14Carcinoma, Squamous Cell 14Carcinoma, Basal Cell 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × INDUSTRY × Cancer Cachexia × Clear all
NCT06476197 2025-07-17

Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy

S-Alpha Therapeutics, Inc.

Phase NA Completed
15 enrolled

Cancer Cachexia

NCT02359123 2018-04-10

Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients

Cannabics Pharmaceuticals Inc.

Phase NA Completed
24 enrolled

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡